Prospecting for genes that might be implicated in cancer, a Vanderbilt University Medical Center research team has struck pay dirt.
Vanderbilt investigators have combined next-generation sequencing technologies and bioinformatics analyses to screen for genome-wide genetic mutations associated with drug resistance in a series of lung cancer cell lines.
Accessibility Tools